Simvastatin causes the formation of cholesterol-rich remnants in mice lacking apoE

Biochemical and Biophysical Research Communications

Volumn 341, Issue 4, 2006, Pages 1172-1176

  Fu, Tao ^a   Borensztajn, Jayme ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

apoB; apoE; Atherosclerosis; Cholesterol; Lipoproteins; Mice; Remnants; Statins

Indexed keywords

APOLIPOPROTEIN B48; APOLIPOPROTEIN E; CHOLESTEROL; LIPOPROTEIN; SIMVASTATIN; TRIACYLGLYCEROL; TYLOXAPOL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAST PROTEIN LIQUID CHROMATOGRAPHY; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CHOLESTEROL; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; MALE; MICE; POLYETHYLENE GLYCOLS; SIMVASTATIN; TRIGLYCERIDES;

ANIMALIA;

EID: 32344447628     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.01.071     Document Type: Article

References (21)

1. H.C. Bucher, L.E. Griffith, and G.H. Guyatt Systematic review on the risk and benefit of different cholesterol-lowering interventions Arterioscler. Thromb. Vasc. Biol. 19 1999 187 195
2. J.K. Liao Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol Am. J. Cardiol. 96 2005 24F 33F
3. S.H. Zhang, R.L. Reddick, J.A. Piedrahita, and N. Maeda Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science 258 1992 468 471
4. A.S. Plump, J.D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells Cell 71 1992 343 353
5. F. Bea, E. Blessing, B. Bennett, M. Levitz, E.P. Wallace, and M.E. Rosenfeld Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering Arterioscler. Thromb. Vasc. Biol. 22 2002 1832 1837
6. Y.X. Wang, B. Martin-McNulty, L.Y. Huw, V. da Cunha, J. Post, J. Hinchman, R. Vergona, M.E. Sullivan, W. Dole, and K. Kauser Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E Atherosclerosis 162 2002 23 31
7. S.H. Quarfordt, B. Oswald, B. Landis, H.S. Xu, S.H. Zhang, and N. Maeda In vivo cholesterol kinetics in apolipoprotein E-deficient and control mice J. Lipid Res. 36 1995 1227 1235
8. R.P. Choudhury, A.L. Carrelli, J.D. Stern, I. Chereshnev, R. Soccio, V.I. Elmalem, J.T. Fallon, E.A. Fisher, and E.D. Reis Effects of simvastatin on plasma lipoproteins and response to arterial injury in wild-type and apolipoprotein-E-deficient mice J. Vasc. Res. 41 2004 75 83
9. T. Fu, P. Kashireddy, and J. Borensztajn The peroxisome-proliferator- activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E Biochem. J. 373 2003 941 947
10. J.C. Fruchart, P. Duriez, and B. Staels Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis Curr. Opin. Lipidol. 10 1999 245 257
11. P. Mardones, A. Pilon, M. Bouly, D. Duran, T. Nishimoto, H. Arai, K.F. Kozarsky, M. Altayo, J.F. Miquel, G. Luc, V. Clavey, B. Staels, and A. Rigotti Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice J. Biol. Chem. 278 2003 7884 7890
12. T. Fu, K.F. Kozarsky, and J. Borensztajn Overexpression of SR-BI by adenoviral vector reverses the fibrate induced hypercholesterolemia of apolipoprotein E-deficient mice J. Biol. Chem. 278 2003 52559 52563
13. I. Inoue, S. Goto, K. Mizotani, T. Awata, T. Mastunaga, S. Kawai, T. Nakajima, S. Hokari, T. Komoda, and S. Katayama Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells Life Sci. 67 2000 863 876
14. N. Roglans, E. Sanguino, C. Peris, M. Alegret, M. Vazquez, T. Adzet, C. Diaz, G. Hernandez, J.C. Laguna, and R.M. Sanchez Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats J. Pharmacol. Exp. Ther. 302 2002 232 239
15. J.F. Landrier, C. Thomas, J. Grober, H. Duez, F. Percevault, M. Souidi, C. Linard, B. Staels, and P. Besnard Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator- activated receptor-alpha-dependent J. Biol. Chem. 279 2004 45512 45518
16. C.P. Sparrow, C.A. Burton, M. Hernandez, S. Mundt, H. Hassing, S. Patel, R. Rosa, A. Hermanowski-Vosatka, P.R. Wang, D. Zhang, L. Peterson, P.A. Detmers, Y.S. Chao, and S.D. Wright Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol-lowering Arterioscler. Thromb. Vasc. Biol. 21 2001 115 121
17. N.O. Davidson, and G.S. Shelness Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation Annu. Rev. Nutr. 20 2000 169 193
18. R.J. Havel Receptor and non-receptor mediated uptake of chylomicron remnants by the liver Atherosclerosis 141 Suppl. 1 1998 S1 S7
19. J. Borensztajn, M.S. Rone, and T.J. Kotlar The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by triton WR-1339 Biochem. J. 156 1976 539 543
20. A. Sato, K. Watanabe, H. Fukuzumi, K. Hase, F. Ishida, and T. Kamei Effect of simvastatin (MK-733) on plasma triacylglycerol levels in rats Biochem. Pharmacol. 41 1991 1163 1172
21. K. Schoonjans, J. Peinado-Onsurbe, J.C. Fruchart, A. Tailleux, C. Fievet, and J. Auwerx 3-hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase FEBS Lett. 452 1999 160 164